ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

Ying Guo; Yuan Zhou; Shohei Yamatomo; Hui Yang; Peng Zhang; Shi Chen; Stephen D. Nimer; Zhizhuang Joe Zhao; Mingjiang Xu; Jie Bai; Feng Chun Yang

doi:10.1038/s41375-018-0347-y

ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

Ying Guo, Yuan Zhou, Shohei Yamatomo, Hui Yang, Peng Zhang, Shi Chen, Stephen D. Nimer, Zhizhuang Joe Zhao, Mingjiang Xu, Jie Bai, Feng Chun Yang

Research output: Contribution to journal › Letter › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	1287-1291
Number of pages	5
Journal	Leukemia
Volume	33
Issue number	5
DOIs	https://doi.org/10.1038/s41375-018-0347-y
State	Published - May 1 2019
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-018-0347-y

Cite this

@article{5d1ae9c5165a40489e69708dfd3828cd,

title = "ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis",

author = "Ying Guo and Yuan Zhou and Shohei Yamatomo and Hui Yang and Peng Zhang and Shi Chen and Nimer, {Stephen D.} and Zhao, {Zhizhuang Joe} and Mingjiang Xu and Jie Bai and Yang, {Feng Chun}",

note = "Funding Information: Acknowledgements This work was supported by grants from the NIH (CA172408 to F-CY and MX), the Leukemia & Lymphoma Society (Specialized Center of Research grant to F-CY, MX, and SDN), and National Natural Science Foundation of China (81770128 to YZ).",

year = "2019",

month = may,

day = "1",

doi = "10.1038/s41375-018-0347-y",

language = "English (US)",

volume = "33",

pages = "1287--1291",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

AU - Guo, Ying

AU - Zhou, Yuan

AU - Yamatomo, Shohei

AU - Yang, Hui

AU - Zhang, Peng

AU - Chen, Shi

AU - Nimer, Stephen D.

AU - Zhao, Zhizhuang Joe

AU - Xu, Mingjiang

AU - Bai, Jie

AU - Yang, Feng Chun

N1 - Funding Information: Acknowledgements This work was supported by grants from the NIH (CA172408 to F-CY and MX), the Leukemia & Lymphoma Society (Specialized Center of Research grant to F-CY, MX, and SDN), and National Natural Science Foundation of China (81770128 to YZ).

PY - 2019/5/1

Y1 - 2019/5/1

UR - http://www.scopus.com/inward/record.url?scp=85060174346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060174346&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0347-y

DO - 10.1038/s41375-018-0347-y

M3 - Letter

C2 - 30651633

AN - SCOPUS:85060174346

SN - 0887-6924

VL - 33

SP - 1287

EP - 1291

JO - Leukemia

JF - Leukemia

IS - 5

ER -

ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this